• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Brought to you by:

Cell & Gene Therapy

Explore the latest news and insight around cell and gene therapy, including new technology and information on treatments in this growing field. See how pharma is leveraging gene therapy and cell therapy to prevent and treat disease.

Brought to you by:
0
Close up of pink azalea flowers
Biotech

In vivo gene editing biotech blossoms from Jennifer Doudna's lab

Azalea Therapeutics will use the funds to push an in vivo CAR-T therapy for B-cell malignancies into the clinic within the next 12 to 18 months.
Darren Incorvaia Nov 4, 2025 8:00am
uturn

uniQure's gene therapy for Huntington's hits FDA roadblock

Nov 3, 2025 10:03am
Job cuts employee layoffs firings or downsizing Scissors dividing individuals positioned on colorful blocks

TScan lays off 30% of workforce, halts solid tumor TCR trial

Nov 3, 2025 8:25am
Closeup of blue eye on black background

Italian biotech raises $141M series B to fund eye gene therapies

Nov 3, 2025 3:00am
Purple cartoon graveyard with castle in the back and giant full moon

The 2025 Biotech Graveyard

Oct 31, 2025 5:00am
Metallic arrow symbols illuminated by blue and magenta lights forming a graph on blue and magenta background

Kyverna links CAR-T to autoimmune improvements in small trial

Oct 29, 2025 10:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings